CME vs CFTC: bitcoin perpetual futures face swap reclassification lawsuit
CME Group plans to sue the US Commodity Futures Trading Commission (CFTC) over its approval of Kalshi’s bitcoin perpetual futures, including BTCPERP. CEO Terrence Duffy says the CFTC misclassified the product and that, under the Dodd-Frank Act, the contracts should be treated as swaps—not futures—making the approval improper. CME plans to file the lawsuit as early as June 18.
CME’s key claim is regulatory classification. Futures and swaps have different Dodd-Frank requirements, including capital, reporting, and eligibility rules. If a court agrees with CME’s view, the legal foundation for Kalshi’s CFTC approval could be weakened, and other exchanges seeking regulated bitcoin perpetual futures in the US may face higher barriers, with more capital and heavier compliance burdens.
This dispute follows Kalshi’s earlier regulatory wins. In April 2026, the US Third Circuit ruled that Kalshi’s sports event contracts fall under CFTC jurisdiction, limiting states’ attempts to treat them as gaming.
The article also notes Coinbase received a CFTC no-action letter around the same time, suggesting perpetual offerings were being brought onshore. However, a court ruling that bitcoin perpetual futures are actually swaps could undermine that comfort.
For crypto traders, the headline risk is legal uncertainty around perpetual access, liquidity, and the compliance path for regulated perpetual products.
Bearish
This is likely bearish because it introduces legal uncertainty around bitcoin perpetual futures in the US. CME is challenging the CFTC’s approval by arguing that these contracts are swaps under Dodd-Frank. If the court agrees, the approvals could be invalidated and the broader path for regulated perpetuals would tighten. That tends to pressure risk appetite for perpetual-related liquidity, increase compliance-related costs, and potentially reduce participation (especially retail), since swap markets have historically been more institution/eligible-participant oriented.
In the short term, traders may front-run headline risk: funding rates and basis-like dynamics for US-accessible perpetuals can react to any expectation of reduced availability or rerouting to other venues. In the long term, the dispute could either (a) force clearer, industry-wide rules via future legislation or (b) trigger a more conservative regulatory regime through litigation precedents.
A parallel is prior regulatory battles where court jurisdiction or product-structure classification changed market access. For example, Kalshi’s earlier sports-event jurisdiction ruling (Third Circuit) showed that legal outcomes can rapidly reshape which products survive under federal oversight. Similarly, if the CME–CFTC classification case escalates, traders should expect repricing of regulatory risk for perpetuals and any exchange planning to launch “regulated” perpetual products under the current framework.